Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis
Clinical Kidney Journal · 03.10.2025 · 18 (10)
DOI: 10.1093/ckj/sfaf286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 11.09.2025. Verfasst von Francesca Di Mario und 11 weiteren Autor:innen. Beteiligte Einrichtung: UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, Università̀ di Parma, Parma, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metformin-associated lactic acidosis (MALA) is a rare but potentially life-threatening complication of metformin therapy, often associated with acute kidney injury (AKI). Sustained low-efficiency dialysis (SLED) offers both haemodynamic stability and effective metformin clearance. However, during regional citrate anticoagulation (RCA), concerns may arise regarding citrate accumulation due to metformin-induced impairment of cellular metabolism. This study assesses the efficacy and safety of SLED with RCA in the management of MALA, providing direct measurements of serum metformin and citrate levels to evaluate drug clearance and potential citrate accumulation.
Methods
A prospective observational study was conducted on consecutive critically ill patients with severe AKI and suspected MALA undergoing a 16-h SLED session with RCA. Demographic, clinical and laboratory data were collected. Serum metformin and citrate levels were measured via high-performance liquid chromatography and enzymatic spectrophotometric analysis, respectively. Mixed effects linear models were used to analyse serum metformin, lactate, citrate, electrolytes and acid–base parameters over time.
Results
Twenty-three patients (median age 79 years; APACHE II score 29) had metformin levels at intensive care unit (ICU) admission above the therapeutic range (median 29.1 mg/l; normal: 0.5–3). ICU mortality was 22% (n = 5). SLED led to significant haemodynamic and acid–base improvements, with a marked reduction in serum lactate. Metformin levels decreased from 27.75 mg/l at SLED start to 3.95 mg/l, with minimal rebound. Four SLED sessions (17%) were interrupted, with one being due to impending circuit clotting. No biochemical or clinical signs of citrate accumulation were observed, with serum citrate levels consistently <0.5 mmol/l. No significant correlation was found between serum metformin and citrate levels or between lactate and citrate.
Conclusions
SLED with RCA is safe and effective in patients with MALA, ensuring adequate KRT duration, rapid metformin clearance and acid–base status restoration. Direct citrate measurements confirmed the absence of accumulation, reinforcing RCA as a viable anticoagulation strategy in this clinical setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, Università̀ di Parma, Parma, Italy.
- Scuola di Specializzazione in Nefrologia, Università di Parma, Dipartimento di Medicina e Chirurgia, Parma, Italy.
- UO Clinica e Patologia Medica, Azienda Ospedaliero‑Universitaria Parma, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.
- Laboratorio di Immunopatologia Renale "Luigi Migone", Università degli Studi di Parma, Parma, Italy.
- Laboratory of Clinical and Experimental Toxicology, Pavia Poison Centre - National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
ORCID-Profile: Francesca Di Mario
Zitieren
APA
Di Mario, F., Regolisti, G., Pacchiarini, M. C., Mordà, B., Greco, P., Maccari, C., Di Motta, T., Oliva, V., Italiano, C., Coccini, T., Roda, E., & Fiaccadori, E. (2025). Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis. Clinical Kidney Journal, 18(10). https://doi.org/10.1093/ckj/sfaf286
Vancouver
Di Mario F, Regolisti G, Pacchiarini MC, Mordà B, Greco P, Maccari C, et al. Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis. Clinical Kidney Journal. 2025;18(10). doi:10.1093/ckj/sfaf286
BibTeX
@article{DiMario2025,
author = {Di Mario, Francesca and Regolisti, Giuseppe and Pacchiarini, Maria Chiara and Mordà, Benedetta and Greco, Paolo and Maccari, Caterina and Di Motta, Tommaso and Oliva, Vincenzo and Italiano, Chiara and Coccini, Teresa and Roda, Elisa and Fiaccadori, Enrico},
title = {Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis},
journal = {Clinical Kidney Journal},
year = {2025},
volume = {18},
number = {10},
doi = {10.1093/ckj/sfaf286}
}
EUVIMED